
ABIVAX SA SP.ADR EO -,01
Depository Receipt · US00370M1036 · ABVX · A3EWCP (XNMS)
6,85 EUR
10.06.2025 19:59
Current Prices from ABIVAX SA SP.ADR EO -,01
Exchange | Ticker | Currency | Last Trade | Price | Daily Change |
---|---|---|---|---|---|
![]() NASDAQ |
ABVX
|
USD
|
10.06.2025 19:59
|
7,82 USD
| 7,76 USD
+0,84 %
|
Performance
Day | Week | Month | 3 Months | 6 Months | 1 Year | 5 Years |
---|---|---|---|---|---|---|
0,00 % | -0,35 % | 15,45 % | 15,94 % | -16,30 % | -47,33 % | -6,88 % |
Company Profile for ABIVAX SA SP.ADR EO -,01 Depository Receipt
ABIVAX Société Anonyme discovers and optimizes drugs for the treatment of inflammatory diseases, infectious diseases, and cancer in France. Its principal products include ABX464 that is in Phase IIb clinical trials for the treatment of ulcerative colitis and Crohn's Disease, as well as for COVID-19; Phase IIa clinical trial for the treatment of rheumatoid arthritis diseases; and has completed Phase IIa clinical trial for the treatment of viral remission in patients with HIV. It also develops ABX 196, an immune enhancer candidate that is in Phase 1/2 clinical trials for the treatment of hepatocellular cancer. In addition, the company engages in the research programs for the treatment of Dengue fever, influenza, and respiratory syncytial virus. ABIVAX Société Anonyme has license contracts with the French National Centre for Scientific Research, the University of Montpellier, and the Institut Curie. The company was incorporated in 2013 and is headquartered in Paris, France.
Company Data
Name ABIVAX SA SP.ADR EO -,01
Company ABIVAX SA
Symbol ABVX
Website
https://www.abivax.com
Primary Exchange
Frankfurt

WKN A3EWCP
ISIN US00370M1036
Asset Class Depository Receipt
Sector Healthcare
Industry Biotechnology
CEO Mr. Marc M. P. de Garidel M.B.A.
Market Capitalization 397 Mio
Country France
Currency EUR
Employees 0,1 T
Address 5, rue de la Baume, 75008 Paris
IPO Date 2023-10-20
Ticker Symbols
Name | Symbol |
---|---|
Frankfurt | 2X10.F |
NASDAQ | ABVX |
More Shares
Investors who ABIVAX SA SP.ADR EO -,01 hold also have the following shares in their portfolio:
The financial platform MoneyPeak tracks and analyzes investments and portfolios.
From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.